A citation-based method for searching scientific literature

Shuang Zhang, Sonia Iyer, Hao Ran, Igor Dolgalev, Shengqing Gu, Wei Wei, Connor J R Foster, Cynthia A Loomis, Narciso Olvera, Fanny Dao, Douglas A Levine, Robert A Weinberg, Benjamin G Neel. Cancer Discov 2021
Times Cited: 10







List of co-cited articles
72 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination Immunotherapy.
Sonia Iyer, Shuang Zhang, Simge Yucel, Heiko Horn, Sean G Smith, Ferenc Reinhardt, Esmee Hoefsmit, Bimarzhan Assatova, Julia Casado, Marie-Charlotte Meinsohn,[...]. Cancer Discov 2021
12
60

Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
Alison M Karst, Keren Levanon, Ronny Drapkin. Proc Natl Acad Sci U S A 2011
195
40


Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
40

Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models.
Ruth Perets, Gregory A Wyant, Katherine W Muto, Jonathan G Bijron, Barish B Poole, Kenneth T Chin, Jin Yun H Chen, Anders W Ohman, Corey D Stepule, Soongu Kwak,[...]. Cancer Cell 2013
324
30

High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.
Yali Zhai, Rong Wu, Rork Kuick, Michael S Sessine, Stephanie Schulman, Megan Green, Eric R Fearon, Kathleen R Cho. J Pathol 2017
49
30

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma.
Shuang Zhang, Igor Dolgalev, Tao Zhang, Hao Ran, Douglas A Levine, Benjamin G Neel. Nat Commun 2019
54
30

CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma.
Josephine Walton, Julianna Blagih, Darren Ennis, Elaine Leung, Suzanne Dowson, Malcolm Farquharson, Laura A Tookman, Clare Orange, Dimitris Athineos, Susan Mason,[...]. Cancer Res 2016
78
30

Development of a syngeneic mouse model for events related to ovarian cancer.
K F Roby, C C Taylor, J P Sweetwood, Y Cheng, J L Pace, O Tawfik, D L Persons, P G Smith, P F Terranova. Carcinogenesis 2000
398
30

Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.
Karen Hoffmann, Hilmar Berger, Hagen Kulbe, Sukanija Thillainadarasan, Hans-Joachim Mollenkopf, Tomasz Zemojtel, Eliane Taube, Silvia Darb-Esfahani, Mandy Mangler, Jalid Sehouli,[...]. EMBO J 2020
16
30

An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity.
Oded Kopper, Chris J de Witte, Kadi Lõhmussaar, Jose Espejo Valle-Inclan, Nizar Hami, Lennart Kester, Anjali Vanita Balgobind, Jeroen Korving, Natalie Proost, Harry Begthel,[...]. Nat Med 2019
195
30

Developing Organoids from Ovarian Cancer as Experimental and Preclinical Models.
Nina Maenhoudt, Charlotte Defraye, Matteo Boretto, Ziga Jan, Ruben Heremans, Bram Boeckx, Florian Hermans, Ingrid Arijs, Benoit Cox, Els Van Nieuwenhuysen,[...]. Stem Cell Reports 2020
25
30

Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Yoshiaki Maru, Naotake Tanaka, Makiko Itami, Yoshitaka Hippo. Gynecol Oncol 2019
45
30


A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids.
Nhan Phan, Jenny J Hong, Bobby Tofig, Matthew Mapua, David Elashoff, Neda A Moatamed, Jin Huang, Sanaz Memarzadeh, Robert Damoiseaux, Alice Soragni. Commun Biol 2019
79
30

Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids.
Sarah J Hill, Brennan Decker, Emma A Roberts, Neil S Horowitz, Michael G Muto, Michael J Worley, Colleen M Feltmate, Marisa R Nucci, Elizabeth M Swisher, Huy Nguyen,[...]. Cancer Discov 2018
132
30

Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses.
Chris Jenske de Witte, Jose Espejo Valle-Inclan, Nizar Hami, Kadi Lõhmussaar, Oded Kopper, Celien Philomena Henrieke Vreuls, Geertruida Nellie Jonges, Paul van Diest, Luan Nguyen, Hans Clevers,[...]. Cell Rep 2020
34
30

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing.
Yoshiko Nanki, Tatsuyuki Chiyoda, Akira Hirasawa, Aki Ookubo, Manabu Itoh, Masaru Ueno, Tomoko Akahane, Kaori Kameyama, Wataru Yamagami, Fumio Kataoka,[...]. Sci Rep 2020
20
30

Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.
Kadi Lõhmussaar, Oded Kopper, Jeroen Korving, Harry Begthel, Celien P H Vreuls, Johan H van Es, Hans Clevers. Nat Commun 2020
22
30

Evaluating cell lines as tumour models by comparison of genomic profiles.
Silvia Domcke, Rileen Sinha, Douglas A Levine, Chris Sander, Nikolaus Schultz. Nat Commun 2013
761
30

Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.
Jeroen Depreeuw, Els Hermans, Stefanie Schrauwen, Daniela Annibali, Lieve Coenegrachts, Debby Thomas, Mathieu Luyckx, Ilse Gutierrez-Roelens, David Debruyne, Katrien Konings,[...]. Gynecol Oncol 2015
31
30

Patient-derived xenografts undergo mouse-specific tumor evolution.
Uri Ben-David, Gavin Ha, Yuen-Yi Tseng, Noah F Greenwald, Coyin Oh, Juliann Shih, James M McFarland, Bang Wong, Jesse S Boehm, Rameen Beroukhim,[...]. Nat Genet 2017
333
30

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Mary L Disis, Matthew H Taylor, Karen Kelly, J Thaddeus Beck, Michael Gordon, Kathleen M Moore, Manish R Patel, Jorge Chaves, Haeseong Park, Alain C Mita,[...]. JAMA Oncol 2019
151
20

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study.
U A Matulonis, R Shapira-Frommer, A D Santin, A S Lisyanskaya, S Pignata, I Vergote, F Raspagliesi, G S Sonke, M Birrer, D M Provencher,[...]. Ann Oncol 2019
187
20

High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
Jaeyeon Kim, Donna M Coffey, Chad J Creighton, Zhifeng Yu, Shannon M Hawkins, Martin M Matzuk. Proc Natl Acad Sci U S A 2012
250
20

Ovarian cancer development and metastasis.
Ernst Lengyel. Am J Pathol 2010
866
20

Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer.
Anniina Färkkilä, Doga C Gulhan, Julia Casado, Connor A Jacobson, Huy Nguyen, Bose Kochupurakkal, Zoltan Maliga, Clarence Yapp, Yu-An Chen, Denis Schapiro,[...]. Nat Commun 2020
68
20

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
853
20

Current Status of Patient-Derived Ovarian Cancer Models.
Yoshiaki Maru, Yoshitaka Hippo. Cells 2019
36
20

Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Shreya Raghavan, Maria R Ward, Katelyn R Rowley, Rachel M Wold, Shuichi Takayama, Ronald J Buckanovich, Geeta Mehta. Gynecol Oncol 2015
64
20

Short-term organoid culture for drug sensitivity testing of high-grade serous carcinoma.
Hui Chen, Kristin Gotimer, Cristabelle De Souza, Clifford G Tepper, Anthony N Karnezis, Gary S Leiserowitz, Jeremy Chien, Lloyd H Smith. Gynecol Oncol 2020
13
20

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
Norman Sachs, Joep de Ligt, Oded Kopper, Ewa Gogola, Gergana Bounova, Fleur Weeber, Anjali Vanita Balgobind, Karin Wind, Ana Gracanin, Harry Begthel,[...]. Cell 2018
525
20

Prospective derivation of a living organoid biobank of colorectal cancer patients.
Marc van de Wetering, Hayley E Francies, Joshua M Francis, Gergana Bounova, Francesco Iorio, Apollo Pronk, Winan van Houdt, Joost van Gorp, Amaro Taylor-Weiner, Lennart Kester,[...]. Cell 2015
20

9
22


Emerging and Evolving Ovarian Cancer Animal Models.
Alexander S Bobbs, Jennifer M Cole, Karen D Cowden Dahl. Cancer Growth Metastasis 2015
33
20

High grade serous ovarian carcinomas originate in the fallopian tube.
S Intidhar Labidi-Galy, Eniko Papp, Dorothy Hallberg, Noushin Niknafs, Vilmos Adleff, Michael Noe, Rohit Bhattacharya, Marian Novak, Siân Jones, Jillian Phallen,[...]. Nat Commun 2017
257
20

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
Y Lee, A Miron, R Drapkin, M R Nucci, F Medeiros, A Saleemuddin, J Garber, C Birch, H Mou, R W Gordon,[...]. J Pathol 2007
571
20

Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Claire F Verschraegen, Wei Hu, Yu Du, John Mendoza, Janet Early, Michael Deavers, Ralph S Freedman, Robert C Bast, Andrzej P Kudelka, John J Kavanagh,[...]. Clin Cancer Res 2003
35
20

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
715
20

Epithelial ovarian cancer.
Stephanie Lheureux, Charlie Gourley, Ignace Vergote, Amit M Oza. Lancet 2019
365
20


Epidemiology of epithelial ovarian cancer.
Penelope M Webb, Susan J Jordan. Best Pract Res Clin Obstet Gynaecol 2017
300
20

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma.
Jennifer Ducie, Fanny Dao, Michael Considine, Narciso Olvera, Patricia A Shaw, Robert J Kurman, Ie-Ming Shih, Robert A Soslow, Leslie Cope, Douglas A Levine. Nat Commun 2017
75
20

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
20

The disparate origins of ovarian cancers: pathogenesis and prevention strategies.
Anthony N Karnezis, Kathleen R Cho, C Blake Gilks, Celeste Leigh Pearce, David G Huntsman. Nat Rev Cancer 2017
146
20


The impact of ovulation on fallopian tube epithelial cells: evaluating three hypotheses connecting ovulation and serous ovarian cancer.
Shelby M King, Tyvette S Hilliard, Lucia Y Wu, Randal C Jaffe, Asgerally T Fazleabas, Joanna E Burdette. Endocr Relat Cancer 2011
89
20

Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube.
Mark A Eckert, Shawn Pan, Kyle M Hernandez, Rachel M Loth, Jorge Andrade, Samuel L Volchenboum, Pieter Faber, Anthony Montag, Ricardo Lastra, Marcus E Peter,[...]. Cancer Discov 2016
96
20

Ovarian cancer.
Bryan T Hennessy, Robert L Coleman, Maurie Markman. Lancet 2009
429
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.